BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:18 PM
 | 
Oct 09, 2012
 |  BC Extra  |  Company News

Institutes to conduct trials of MedImmune mAbs

The Cancer Research Institute and the Ludwig Institute for Cancer Research will conduct clinical trials of cancer immunotherapy combinations, including three mAbs from MedImmune LLC combined with other immunotherapies that have yet to be...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >